Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

223
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
223
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

199
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
199
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

303
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
303
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

365
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
365

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of SARS-CoV-2 infection with incident diabetes among U.S. Veterans in a prospective longitudinal cohort.

PloS one·2026
Same author

Erysipelothrix rhusiopathiae Prosthetic Joint Infection of the Knee in an Immunocompromised Patient.

Cureus·2026
Same author

Antibiotic Duration after Debridement and Implant Retention for Early Postoperative Spinal Implant Infections: A Multicenter Cohort Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Evaluation of outcomes associated with antipseudomonal beta-lactams for treatment of methicillin-susceptible <i>Staphylococcus aureus</i> bacteremia: a retrospective cohort analysis.

Therapeutic advances in infectious disease·2025
Same author

Case report of peritoneal dialysis-associated peritonitis caused by <i>Mycobacterium abscessus</i> in a child, successfully treated with dual β-lactam combination therapy.

ASM case reports·2025
Same author

2025 ICM: Anesthesia.

The Journal of arthroplasty·2025
Same journal

Retraction: The Association Between Janus Kinase 2 and Factor V Leiden Mutations and Thrombotic Complications in Patients With Myeloproliferative Disorders: A Study From Saudi Arabia.

Cureus·2026
Same journal

Patient-Reported Understanding of Emergency Department Discharge Instructions, Satisfaction, and Acceptability of a Future Telemedicine-Based Call-Back Program: Phase 1 Observational Pilot Study at a Tertiary Hospital in Dubai, United Arab Emirates.

Cureus·2026
Same journal

Correction: Methylprednisolone-Induced Delayed and Sustained Bradycardia in Multisystem Inflammatory Syndrome in Children.

Cureus·2026
Same journal

Rapid Interval Development of a Left Hepatic Artery Pseudoaneurysm During Acute Interstitial Edematous Pancreatitis.

Cureus·2026
Same journal

Recurrent Acute Pancreatitis Secondary to Untreated Hyperparathyroidism: A Case Report and Literature Review.

Cureus·2026
Same journal

A Prospective Case-Control Study of Helicobacter pylori and Systemic Inflammation in Colorectal Cancer Pathogenesis.

Cureus·2026
See all related articles

Related Experiment Video

Updated: Jan 9, 2026

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
10:35

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction

Published on: December 3, 2017

11.5K

Rifampin Use in Staphylococcal Prosthetic Joint Infections.

Kunjan Shah1, Christopher B Baladad1, Alaina S Ritter2

  • 1Department of Pharmacy, University of Florida Health Shands Hospital, Gainesville, USA.

Cureus
|December 8, 2025
PubMed
Summary
This summary is machine-generated.

Adjunctive rifampin significantly reduced treatment failure rates in patients with staphylococcal prosthetic joint infections (PJI). This study found a lower incidence of treatment failure in the rifampin group compared to the non-rifampin group for PJI management.

Keywords:
adverse eventsprosthetic joint infection (pji)rifampinstaphylococcal pjitreatment duration

More Related Videos

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections
04:37

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections

Published on: February 2, 2024

1.2K
A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.7K

Related Experiment Videos

Last Updated: Jan 9, 2026

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
10:35

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction

Published on: December 3, 2017

11.5K
Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections
04:37

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections

Published on: February 2, 2024

1.2K
A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.7K

Area of Science:

  • Orthopedics
  • Infectious Diseases
  • Pharmacology

Background:

  • Prosthetic joint infection (PJI) is a severe complication of joint replacement surgery.
  • Current treatment guidelines often recommend rifampin for staphylococcal PJI, but its efficacy is debated.
  • The debridement, antibiotics, and implant retention (DAIR) approach is common for PJI management.

Purpose of the Study:

  • To evaluate the impact of adjunctive rifampin on treatment outcomes in patients with staphylococcal PJI.
  • To compare treatment failure rates between patients receiving rifampin and those not receiving it.
  • To assess secondary outcomes including implant survival and adverse events.

Main Methods:

  • Retrospective study of patients aged over 18 with staphylococcal PJI from 2016-2021.
  • Patients managed with DAIR were analyzed, excluding those requiring implant resection or amputation.
  • Primary endpoint was treatment failure; secondary endpoints included implant removal and adverse events.

Main Results:

  • 34 patients included: 16 in the rifampin (RIF) group and 18 in the non-rifampin (non-RIF) group.
  • Treatment failure occurred in 12.5% of RIF patients vs. 50% of non-RIF patients (P=0.030).
  • Most patients in both groups underwent DAIR; methicillin-susceptible *Staphylococcus aureus* (MSSA) was the most common pathogen.

Conclusions:

  • Adjunctive rifampin demonstrated a statistically significant benefit in treating staphylococcal PJI.
  • Lower treatment failure rates were observed in patients receiving rifampin.
  • Despite study limitations, rifampin may be a valuable component in PJI management.